Clinical Trial Update: Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Botulinum Toxin A (Botox) in tissue expander breast reconstruction has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Postoperative Pain

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer, Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2019-10-10